Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mills Biopharmaceuticals

1992 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
4 FINANCING ROUNDS
Description

Provider of brachytherapy treatment services. The company is engaged in supplying of Iodine 125 and Palladium Pd-103 seeds for low dose prostate brachytherapy treatment.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Drug Delivery
Pharmaceuticals
Acquirer
Primary Office
  • 120 NorthEast 26th Street
  • Oklahoma City, OK 73105
  • United States

Mills Biopharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Mills Biopharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Mills Biopharmaceuticals Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Mills Biopharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Mills Biopharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Stanley Mills Founder & President